Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CCD-3693 marketing agreement announced by CoCensys and Searle

May 31, 1996

Hyal's 3% diclofenac gel: Positive phase III results announced

May 31, 1996

Shanghai Institute of Materia Medica reveals epibatidine analogue

May 31, 1996

New bradykinin antagonists from Sanofi Winthrop

May 31, 1996

Astra reveals analgesic and immunosuppressive agents

May 31, 1996

HMR discloses 5-HT reuptake inhibitors

May 24, 1996

Sankyo's calpain inhibitor for neurological disorders, restenosis

May 24, 1996

E. Merck describes NMDA ligands for neurodegeneration

May 24, 1996

Lilly's new series of muscarinic cholinergic receptor agonists

May 24, 1996

Biogen introduces Avonex in first market

May 24, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...